- Survival After Oxaliplatin Therapy of Irinotecan-pretreated Advanced Colorectal Cancer Patients2005 | Publication without faculty affiliation
- Survival After Oxaliplatin Therapy of Irinotecan-pretreated Advanced Colorectal Cancer Patients2005 | First Faculty of Medicine
- Capecitabin e and oxaliplatin (XELOX) in adjuvant therapy of colorectal cancer. Results of the NO16968 (XELOXA) trial2010 | First Faculty of Medicine
- Survival After Oxaliplatin Therapy of Irinotecan-pretreated Advanced Colorectal Cancer Patients +12005 | Faculty of Medicine in Hradec Králové
- Plicní fibróza po oxaliplatině2015 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment TPU-S1119Publication without faculty affiliation
- Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis2014 | First Faculty of Medicine
- Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma2012 | Faculty of Medicine in Hradec Králové
- Lonsurf plus bevacizumab: A new standard in the third-line treatment of metastatic colorectal carcinoma2023 | Publication without faculty affiliation
- Oxaliplatin and irinotecan induce heterogenous changes in the EMT markers of metastasizing colorectal carcinoma cells2018 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer2017 | Publication without faculty affiliation
- Sinusoidal obstruction syndrome induced by monocrotaline in a large animal experiment - a pilot study2018 | Faculty of Medicine in Pilsen
- Antiproliferative Effects of Hop-derived Prenylflavonoids and Their Influence on the Efficacy of Oxaliplatine, 5-fluorouracil and Irinotecan in Human ColorectalC Cells2019 | Faculty of Pharmacy in Hradec Králové
- The current view of the pharmacotherapy of inoperable metastatic colorectal cancer2015 | First Faculty of Medicine
- EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer2008 | Second Faculty of Medicine
- Sesquiterpenes alpha-humulene and beta-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells2019 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Prognostic factors of survival after oxaliplatin therapy in colorectal cancer patients pretreated by irinotecanPublication without faculty affiliation
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy2015 | Publication without faculty affiliation
- Serum homocysteine, cholesterol, retinol, alfa-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatiin, 5-fluorouracil and leucovorin2009 | Faculty of Medicine in Hradec Králové
- FOLFOX/FOLFIRI pharmacogenetics: The call for a personalized approach in colorectal cancer therapy2014 | Faculty of Medicine in Pilsen
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | Second Faculty of Medicine
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin2009 | Central Library of Charles University
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin2009 | Faculty of Pharmacy in Hradec Králové
- Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin2009 | First Faculty of Medicine
- Interactions of Platinum-Based Cytostatics with Metallothionein Revealed by Electrochemistry2013 | Faculty of Science, Second Faculty of Medicine
- A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome2019 | Faculty of Medicine in Pilsen
- Efficacy of trifluridine / tipiracil in a pre-treated patient with generalized sigma cancer2019 | Publication without faculty affiliation